Gene · 699
Papers3,725
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
561 to 580 of 3,725
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Female Germ Cell Development in Chickens and Humans: The Chicken Oocyte Enriched Genes Convergent and Divergent with the Human Oocyte. | Int J Mol Sci | 2022 | 36232712 | PubTator, text mining | PubMed |
| Inhibition of Mps1 kinase enhances taxanes efficacy in castration resistant prostate cancer. | Cell Death Dis | 2022 | 36229449 | PubTator, text mining | PubMed |
| Construction of novel lncRNA-miRNA-mRNA ceRNA networks associated with prognosis of hepatitis C virus related hepatocellular carcinoma. | Heliyon | 2022 | 36217480 | PubTator, text mining | PubMed |
| Identification of Prognostic Markers and Potential Therapeutic Targets in Gastric Adenocarcinoma by Machine Learning Based on mRNAsi Index. | J Oncol | 2022 | 36213825 | PubTator, text mining | PubMed |
| Potential methylation-regulated genes and pathways in hepatocellular neoplasm, not otherwise specified. | Front Oncol | 2022 | 36212481 | PubTator, text mining | PubMed |
| A multi-omic analysis of MCF10A cells provides a resource for integrative assessment of ligand-mediated molecular and phenotypic responses. | Commun Biol | 2022 | 36207580 | PubTator, text mining | PubMed |
| Analysis and identification of potential type II helper T cell (Th2)-Related key genes and therapeutic agents for COVID-19. | Comput Biol Med | 2022 | 36201886 | PubTator, text mining | PubMed |
| Identifying the genes impacted by cell proliferation in proteomics and transcriptomics studies. | PLoS Comput Biol | 2022 | 36201535 | PubTator, text mining | PubMed |
| Upregulation of circ_0008812 and circ_0001583 predicts poor prognosis and promotes breast cancer proliferation. | Front Mol Biosci | 2022 | 36200070 | PubTator, text mining | PubMed |
| Common and species-specific molecular signatures, networks, and regulators of influenza virus infection in mice, ferrets, and humans. | Sci Adv | 2022 | 36197970 | PubTator, text mining | PubMed |
| Knockdown of RAD51AP1 suppressed cell proliferation and invasion in esophageal squamous cell carcinoma. | Discov Oncol | 2022 | 36197550 | PubTator, text mining | PubMed |
| Investigating the Lung Adenocarcinoma Stem Cell Biomarker Expressions Using Machine Learning Approaches. | Biomed Res Int | 2022 | 36193299 | PubTator, text mining | PubMed |
| CDC20 May Serve as a Potential Biomarker-Based Risk Score System in Predicting the Prognosis of Patients with Hepatocellular Carcinoma. | Oxid Med Cell Longev | 2022 | 36193067 | PubTator, text mining | PubMed |
| Dissecting novel mechanisms of hepatitis B virus related hepatocellular carcinoma using meta-analysis of public data. | World J Gastrointest Oncol | 2022 | 36187396 | PubTator, text mining | PubMed |
| ASPM, CDC20, DLGAP5, BUB1B, CDCA8, and NCAPG May Serve as Diagnostic and Prognostic Biomarkers in Endometrial Carcinoma. | Genet Res (Camb) | 2022 | 36186000 | PubTator, text mining | PubMed |
| PLK1 as one novel target for the poor prognosis of bladder cancer: An observational study. | Medicine (Baltimore) | 2022 | 36181054 | PubTator, text mining | PubMed |
| Targeting epigenetic regulators for inflammation: Mechanisms and intervention therapy. | MedComm (2020) | 2022 | 36176733 | PubTator, text mining | PubMed |
| Identification and verification of hub genes associated with the progression of non-small cell lung cancer by integrated analysis. | Front Pharmacol | 2022 | 36176446 | PubTator, text mining | PubMed |
| A cancer stem cell associated gene signature for predicting overall survival of hepatocellular carcinoma. | Front Genet | 2022 | 36171884 | PubTator, text mining | PubMed |
| Tumor microenvironment gene expression profiles associated to complete pathological response and disease progression in resectable NSCLC patients treated with neoadjuvant chemoimmunotherapy. | J Immunother Cancer | 2022 | 36171009 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/699/papers?page=29